Works matching AU Tsukamoto, N.


Results: 28
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    A PHASE 2B OPEN‐LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF HBI‐8000 (TUCIDINOSTAT) IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA (PTCL)

    Published in:
    Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.121_2880
    By:
    • Kim, W. S.;
    • Rai, S.;
    • Ando, K.;
    • Choi, I.;
    • Izutsu, K.;
    • Tsukamoto, N.;
    • Yokoyama, M.;
    • Tsukasaki, K.;
    • Kuroda, J.;
    • Ando, J.;
    • Hidaka, M.;
    • Koh, Y.;
    • Shibayama, H.;
    • Uchida, T.;
    • Yang, D. H.;
    • Ishitsuka, K.;
    • Ishizawa, K.;
    • Kim, J. S.;
    • Lee, H. G.;
    • Minami, H.
    Publication type:
    Article
    12
    13
    14
    15

    Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up.

    Published in:
    1986
    By:
    • Kashimura, Yoshiko;
    • Kashimura, Masamichi;
    • Sugimori, Hajime;
    • Tsukamoto, Naoki;
    • Matsuyama, Toshitaka;
    • Matsukuma, Keita;
    • Kamura, Toshiharu;
    • Saito, Toshiaki;
    • Kawano, Hideaki;
    • Nose, Reiko;
    • Nose, Yoshiaki;
    • Nakano, Hito;
    • Taki, Ichiro;
    • Kashimura, Y;
    • Kashimura, M;
    • Sugimori, H;
    • Tsukamoto, N;
    • Matsuyama, T;
    • Matsukuma, K;
    • Kamura, T
    Publication type:
    journal article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28